Stockreport

Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Vivos Therapeutics, Inc.  (VVOS) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst es [Read more]